Dynamic CD138 Surface Expression Regulates Switch Between Myeloma Growth and Dissemination

Leukemia - United Kingdom
doi 10.1038/s41375-019-0519-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Vascular Endothelial Growth Factor Receptor 3 Is a Novel Marker Differing CD138-positive and CD138-negative Multiple Myeloma Cells

British Journal of Haematology
Hematology
2017English

Hypoxia Reduces CD138 Expression and Induces an Immature and Stem Cell-Like Transcriptional Program in Myeloma Cells

International Journal of Oncology
Cancer ResearchOncology
2013English

A Stress-Responsive RNA Switch Regulates VEGFA Expression

Nature
Multidisciplinary
2008English

HDAC3 Regulates DNMT1 Expression in Multiple Myeloma: Therapeutic Implications

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2017English

Dlx1&2-Dependent Expression of Zfhx1b (Sip1, Zeb2) Regulates the Fate Switch Between Cortical and Striatal Interneurons

Neuron
Neuroscience
2013English

MicroRNA-188 Regulates Age-Related Switch Between Osteoblast and Adipocyte Differentiation

Journal of Clinical Investigation
Medicine
2015English

A Multiepitope of XBP1, CD138 and CS1 Peptides Induces Myeloma-Specific Cytotoxic T Lymphocytes in T Cells of Smoldering Myeloma Patients

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2014English

A CD138-independent Strategy to Detect Minimal Residual Disease and Circulating Tumour Cells in Multiple Myeloma

British Journal of Haematology
Hematology
2016English

Casein Kinase 2 Phosphorylates GluA1 and Regulates Its Surface Expression

European Journal of Neuroscience
Neuroscience
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy